Cite
Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry).
MLA
Rakowski, Tomasz, et al. “Impact of Infarct Related Artery Patency after Early Abciximab Administration on One-Year Mortality in Patients with ST-Segment Elevation Myocardial Infarction (Data from the EUROTRANSFER Registry).” Kardiologia Polska, vol. 70, no. 3, 2012, pp. 215–21. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=22430397&authtype=sso&custid=ns315887.
APA
Rakowski, T., Siudak, Z., Dziewierz, A., Birkemeyer, R., Janzon, M., Mielecki, W., Zmudka, K., Dubiel, J. S., & Dudek, D. (2012). Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry). Kardiologia Polska, 70(3), 215–221.
Chicago
Rakowski, Tomasz, Zbigniew Siudak, Artur Dziewierz, Ralf Birkemeyer, Magnus Janzon, Waldemar Mielecki, Krzysztof Zmudka, Jacek S Dubiel, and Dariusz Dudek. 2012. “Impact of Infarct Related Artery Patency after Early Abciximab Administration on One-Year Mortality in Patients with ST-Segment Elevation Myocardial Infarction (Data from the EUROTRANSFER Registry).” Kardiologia Polska 70 (3): 215–21. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=22430397&authtype=sso&custid=ns315887.